sulfan blue has been researched along with Breast Cancer, Male in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sleth, JC | 1 |
| Avisar, E; Schuman, S; Walker, G | 1 |
| de Kanter, AY; Eggermont, AM; Henzen-Logmans, SC; Krenning, EP; Kruyt, RH; Paul, MA; van Eijck, CH; van Geel, AN; Wiggers, T | 1 |
1 trial(s) available for sulfan blue and Breast Cancer, Male
| Article | Year |
|---|---|
Controlled introduction of the sentinel node biopsy in breast cancer in a multi-centre setting: the role of a coordinator for quality control.
Topics: Axilla; Breast Neoplasms; Breast Neoplasms, Male; Coloring Agents; Female; Humans; Lymph Nodes; Male; Multicenter Studies as Topic; Quality Control; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Technetium Tc 99m Aggregated Albumin; Ultrasonography | 2000 |
2 other study(ies) available for sulfan blue and Breast Cancer, Male
| Article | Year |
|---|---|
[Anaphylaxis due to patent blue. Time to change dye?].
Topics: Adenofibroma; Anaphylaxis; Breast Neoplasms, Male; Ephedrine; Humans; Male; Middle Aged; Rosaniline Dyes; Treatment Outcome | 2008 |
Processing sentinel nodes in breast cancer: when and how many?
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Breast Neoplasms, Male; Coloring Agents; Cost-Benefit Analysis; False Negative Reactions; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Palpation; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Rosaniline Dyes; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2011 |